2014
DOI: 10.1001/jama.2014.4313
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Effectiveness Research and Outcomes of Diabetes Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 10 publications
0
8
0
Order By: Relevance
“…19, 20 Insulin use among people with diabetes may be a marker of both more severe disease and an increased risk of CVD. 21, 22 Using data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study, we compared the risk of CHD events between participants with diabetes but no prevalent CHD and those with prevalent CHD but no diabetes and investigated whether the relative risk of CHD events associated with diabetes versus history of CHD varied by age. Additionally, we investigated the risk of CHD events associated with more severe diabetes, defined as diabetes with insulin use and/or albuminuria.…”
mentioning
confidence: 99%
“…19, 20 Insulin use among people with diabetes may be a marker of both more severe disease and an increased risk of CVD. 21, 22 Using data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study, we compared the risk of CHD events between participants with diabetes but no prevalent CHD and those with prevalent CHD but no diabetes and investigated whether the relative risk of CHD events associated with diabetes versus history of CHD varied by age. Additionally, we investigated the risk of CHD events associated with more severe diabetes, defined as diabetes with insulin use and/or albuminuria.…”
mentioning
confidence: 99%
“…While randomized control trials (RCT) are often considered the gold standard for advancing scientific knowledge creation (Safford, 2014 ), this methodology is expensive, time intensive, and frequently not an appropriate approach for most research questions (Dreyer et al, 2010 ; Safford, 2014 ) because, the results from RCTs do not always match what is observed in real-world practice or can account for meaningful changes in the local environment as the study progresses (Dreyer et al, 2010 ). Comparative effectiveness research (CER) consisting of observational studies that are well-designed and which analyze data from large population samples can address questions that are not possible to answer using a RCT methodology alone (Dreyer et al, 2010 ; Safford, 2014 ). Intervention research is a significant CER study design and has been adopted by the National Center as the favored approach to generate data, produce information translated into knowledge.…”
Section: What Do We Need To Know To Establish Ipecp As An Effective Amentioning
confidence: 99%
“…RCTs have been challenged for failing to predict real‐world outcomes . The inherent poor external validity of RCTs limits the study results for generalization to more complex patient populations in real‐world clinical practice, raising concerns that more generalizable results are needed to better inform real‐world clinical decisions . Observational studies are positioned to assess the safety and effectiveness in the real‐world environment .…”
Section: Introductionmentioning
confidence: 99%
“…13 The inherent poor external validity of RCTs limits the study results for generalization to more complex patient populations in real-world clinical practice, 14 raising concerns that more generalizable results are needed to better inform real-world clinical decisions. 15 Observational studies are positioned to assess the safety and effectiveness in the real-world environment. 16,17 However, large-scale comparisons of complex insulin regimens in real-world settings, in combination with oral antidiabetic drugs (OADs), are lacking.…”
Section: Introductionmentioning
confidence: 99%